GPHRA and invasive breast carcinoma: Increased GPR89A expression levels were also found in many other cancer types, for example, breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), and cholangiocarcinoma (CHOL) (Fig. 3E).